Sildenafil improves the alveolar-capillary function in heart failure patients

International Journal of Cardiology

Volumn 126, Issue 1, 2008, Pages 68-72

  Bussotti, Maurizio ^a   Montorsi, Piero ^a   Amato, Mauro ^a   Magini, Alessandra ^a   Baldassarre, Damiano ^a   Tantardini, Francesca ^c   Veglia, Fabrizio ^a   Agostoni, Piergiuseppe ^a,b  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Erectile dysfunction; Exercise; Heart failure; Lung diffusion

Indexed keywords

AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC OXIDE; SILDENAFIL;

ADULT; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SAFETY; EXERCISE; EXHALATION; HEART FAILURE; HUMAN; LUNG ALVEOLUS; LUNG CAPILLARY; LUNG DIFFUSION; LUNG EDEMA; LUNG FUNCTION; MALE; MECHANICS; PRIORITY JOURNAL; REST;

AGED; CAPILLARY PERMEABILITY; EXERCISE TEST; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMANS; MALE; MAXIMAL VOLUNTARY VENTILATION; MIDDLE AGED; PIPERAZINES; PULMONARY ALVEOLI; PULMONARY DIFFUSING CAPACITY; PURINES; SULFONES; VITAL CAPACITY;

EID: 41949091632     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.03.118     Document Type: Article

References (30)

1. Farber H.W., and Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351 (2004) 1655-1665
2. Webster L.J., Michelakis E.D., Davis T., and Archer S.L. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association Classes II and III Congestive Heart Failure. Arch Intern Med 164 (2004) 514-520
3. Bocchi E.A., Guimaraes G., Mocelin A., Bacal F., Bellotti G., and Ramires J.F. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure. Circulation 106 (2002) 1097-1103
4. Guazzi M., Tumminello G., Di Marco F., and Guazzi M.D. Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure. Clin Pharmacol Ther 76 (2004) 371-378
5. Guazzi M., Tumminello G., Di Marco F., Fiorentini C., and Guazzi M.D. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 44 12 (Dec 21 2004) 2339-2348
6. Kleinsasser A., and Loeckinger A. Are sildenafil and theophylline effective in the prevention of altitude pulmonary edema?. Med Hypotheses 59 (2002) 223-225
7. Ghofrani H.A., Reichenberger F., Kohstall M.G., et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomised, double blind, placebo-controlled crossover trial. Ann Intern Med 141 (2004) 169-177
8. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144 (1991) 1202-1218
9. Hansen J., Sue D., and Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 129 (1984) S49-S55
10. Quanjer P.H., Tammelling G.J., and Cotes J.E. Standardized lung function testing. Eur Respir J 6 (1993) 1-99
11. Jones N.L. Clinical exercise testing. Third ed. (1988), WB Saunders, Philadelphia, PA 306-311
12. Huang Y.C., Helmes M.J., and MacIntyre N.R. Normal values for single exhalation diffusing capacity and pulmonary capillary blood flow in sitting, supine position, and during mild exercise. Chest 105 (1994) 501-506
13. Roughton F.J.W., and Forster F.E. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in human lung, with special reference to true diffusing capacity of blood in the lung capillaries. J Appl Physiol 11 (1957) 290-302
14. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 160 (1999) 2104-2117
15. Zetterquist W., Pedroletti C., Lundberg J.O.N., and Alving K. Salivary contribution to exhaled nitric oxide. Eur Respir J 13 (1999) 327-333
16. Agostoni P.G., Bianchi M., Moraschi A., et al. Work rate affects cardiopulmonary exercise test results in heart failure. Eur J Heart Fail 7 (2005) 498-504
17. Beaver W.L., Wasserman K., and Whipp B.J. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60 (1986) 2020-2027
18. SAS Institute Inc. SAS/Stat User's guide, Version 6. Fourth Edition vol. 2 (1989), SAS Institute Inc., Cary, NC, USA 951-957
19. Agostoni P.G., Cattadori G., Bianchi M., and Wasserman K. Exercise-induced pulmonary edema in heart failure. Circulation 108 (2003) 2666-2671
20. Goldstein I., Lue T.F., Padma-Nathan H., et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338 (1998) 1397-1404
21. Katz S.D., Balidemaj K., Homma S., Wu H., Wang J., and Maybaum S. Acute Type 5 phosphodiesterase Inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol 36 (2000) 845-851
22. Alaeddini J., Uber P.A., Park M.H., Scott R.L., Ventura H.O., and Mehra MR. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am J Cardiol 94 (2004) 1475-1477
23. Medina P., Segarra G., Vila J.M., Domenech C., Martinez-Leon J.B., and Lluch S. Effects of Sildenafil on human penile blood vessels. Urology 56 (2000) 539-543
24. Hansen J.E., Sue D.Y., Oren A., and Wasserman K. Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol 59 (1987) 669-674
25. Wasserman K., Zhang Y.Y., Gitt A., et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 96 (1997) 2221-2227
26. Agostoni P., Bussotti M., Cattadori G., et al. Gas diffusion and alveolar-capillary unit in chronic heart failure. Eur Heart J 27 (2006) 2538-2543
27. Agostoni P.G., Bussotti M., Palermo P., and Guazzi M. Does lung diffusion impairment affect exercise capacity in patients with heart failure?. Heart 88 (2002) 453-459
28. Koike A., Wasserman K., McKenzie D.K., Zanconato S., and Weiler-Ravell D. Evidence that diffusion limitation determines oxygen uptake kinetics during exercise in humans. J Clin Invest 86 (1990) 1698-1706
29. Bussotti M., Andreini D., and Agostoni P.G. Exercise-induced changes in exhaled nitric oxide in heart failure. Eur J Heart Fail 6 (2004) 551-554
30. Kukreja R.C., Ockaili R., Salloum F., and Xi L. Sildenafil-induced cardioprotection in rabbits. Cardiovasc Res 60 (2003) 700-701